{"organizations": [], "uuid": "38ae0c791b01a20473fd7da29b5e3ce7e94f531e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-protagonist-therapeutics-granted-t/brief-protagonist-therapeutics-granted-two-new-us-patents-for-peptide-drug-candidates-ptg-100-and-ptg-300-idUSFWN1OZ0PS", "country": "US", "domain_rank": 408, "title": "BRIEF-Protagonist Therapeutics Granted Two New US Patents For Peptide Drug Candidates PTG-100 And PTG-300", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-04T15:24:00.000+02:00", "replies_count": 0, "uuid": "38ae0c791b01a20473fd7da29b5e3ce7e94f531e"}, "author": "", "url": "https://www.reuters.com/article/brief-protagonist-therapeutics-granted-t/brief-protagonist-therapeutics-granted-two-new-us-patents-for-peptide-drug-candidates-ptg-100-and-ptg-300-idUSFWN1OZ0PS", "ord_in_thread": 0, "title": "BRIEF-Protagonist Therapeutics Granted Two New US Patents For Peptide Drug Candidates PTG-100 And PTG-300", "locations": [], "entities": {"persons": [], "locations": [{"name": "new us", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "brief-protagonist therapeutics granted two new us patents for peptide drug candidates", "sentiment": "negative"}, {"name": "peptide drug candidates", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "protagonist therapeutics inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 4, 2018 / 1:24 PM / Updated 11 minutes ago BRIEF-Protagonist Therapeutics Granted Two New US Patents For Peptide Drug Candidates PTG-100 And PTG-300 Reuters Staff 1 Min Read \nJan 4 (Reuters) - Protagonist Therapeutics Inc: \n* PROTAGONIST THERAPEUTICS GRANTED TWO NEW US PATENTS FOR PEPTIDE DRUG CANDIDATES PTG-100 AND PTG-300 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-04T15:24:00.000+02:00", "crawled": "2018-01-04T15:39:55.006+02:00", "highlightTitle": ""}